[Federal Register Volume 77, Number 202 (Thursday, October 18, 2012)]
[Notices]
[Page 64143]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-25634]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Cambridge Isotope Lab

    By Notice dated June 18, 2012, and published in the Federal 
Register on June 26, 2012, 77 FR 38086, Cambridge Isotope Lab, 50 
Frontage Road, Andover, Massachusetts 01810, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of Morphine (9300), a basic class of controlled 
substance listed in schedule II.
    The company plans to utilize small quantities of the listed 
controlled substance in the preparation of analytical standards.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Cambridge Isotope Lab to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Cambridge Isotope Lab to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic class of controlled substance listed.

    Dated: October 9, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-25634 Filed 10-17-12; 8:45 am]
BILLING CODE 4410-09-P